Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
April 24, 2020 at 05:32 am EDT
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 437.886 million compared to CNY 458.461 million a year ago. Operating loss was CNY 486.857 million compared to operating Income of CNY 43.442 million a year ago. Net loss was CNY 465.329 million compared to net income of CNY 45.746 million a year ago. Basic loss per share from continuing operations was CNY 1.75 compared to basic earnings per share from continuing operations of CNY 0.17 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.
GUANHAO BIOTECH CO.,LTD. 
